Clik here to view.
AVITA Medical Names David McIntyre as Chief Financial Officer
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in...
View ArticleClik here to view.
ITM and CIRC Sign Technology License Agreement for the Production and...
MUNICH & GARCHING, Germany ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and Chengdu Gaotong Isotope Co., Ltd. a subsidiary of China...
View ArticleClik here to view.
Kraig Biocraft Laboratories Completes Scale-Up Production Cycle of...
ANN ARBOR, Mich. Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that Prodigy Textiles, the Company’s Vietnamese...
View ArticleClik here to view.
FDA Accepts Samsung Bioepis’ BLA for SB8 Bevacizumab Biosimilar Candidate
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s Biologics License Application (BLA) under the 351(k)...
View ArticleClik here to view.
EdiGene to Present Data on Manufacturing Scale-up and Preclinical Development...
BEIJING & CAMBRIDGE, Mass. EdiGene, Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery,...
View ArticleClik here to view.
Mevion Signs Agreement to Bring Proton Therapy to Central Taiwan
LITTLETON, Mass. Mevion Medical Systems today announced it had signed a collaborative framework agreement with Chung Shan Medical University Hospital and ASYS Corp to provide advanced proton therapy...
View ArticleClik here to view.
Nanox Introduces Digital X-ray Technology
NAVE ILAN, Israel Nano-X Imaging Ltd. (“Nanox” or the “Company”), a medical imaging technology company, introduces the first commercial-grade digital X-ray technology based on a proprietary silicon...
View ArticleClik here to view.
路胜生物完成由IHH Healthcare领投的2千万美元A轮投资，用于推动液体活检技术，进行多种癌症早期检测
新加坡 (美国商业资讯)– 路胜生物(Lucence)，发明用于癌症筛查, 治疗选择的血液检测的基因组医学公司，今天宣布完成2千万美元A轮融资。此轮融资的领投者是全球最大的综合私人医疗保健集团之一IHH Healthcare。参投者包括新加坡创新机构(SGInnovate)，以及现有投资者淡马锡控股(Temasek Holdings) 旗下的海丽凯资本管理公司(Heliconia...
View ArticleClik here to view.
Lucence Raises USD $20M Series A Led by IHH Healthcare to Advance Liquid...
SINGAPORE Lucence, a genomic medicine company that invents blood-based tests for cancer screening and treatment selection, announced today the close of USD $20 million in Series A funding. The round...
View ArticleClik here to view.
Clik here to view.
Asian Entrepreneurship Award 2019: Acumen Research Labs of Singapore Wins...
CHIBA, Japan The Asian Entrepreneurship Award Steering Committee announced today that Acumen Research Labs of Singapore won first prize at the Asian Entrepreneurship Awards 2019 (AEA 2019), a...
View ArticleClik here to view.
Study Uses Masimo Patient SafetyNet™ and rainbow Acoustic Monitoring® to...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers at Nippon Medical School in Tokyo,...
View ArticleClik here to view.
PENTAX Medical Launches DEC™ HD Duodenoscope in the United States
MONTVALE, N.J. PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy, has announced the United States launch of its DEC™ HD Duodenoscope, an advanced, high-definition...
View ArticleClik here to view.
Phenomics Health Inc. 收购专利药物代谢组技术
密西根州安娜堡 (美国商业资讯)–基于生物信息学平台的精准医学公司Phenomics Health Inc.今天宣布，其已收购总部位于美国田纳西州富兰克林的Precera Bioscience公司的专利药物代谢组技术组合。 Phenomics Health计划将该新技术与自身的专利先进药物基因组平台相整合，在患者对用药的潜在和实际应答方面，向医疗保健提供者提供比现有技术更完整的图景。...
View ArticleClik here to view.
Zymeworks在ESMO亚洲大会上宣布推进与百济神州的临床合作并公布ZW25用于治疗HER2呈阳性癌症患者的1期临床研究更新数据
新加坡 (美国商业资讯)– Zymeworks Inc. (NYSE: ZYME)是一家处于临床开发阶段、专注于多功能治疗药物开发的生物制药公司。公司今天宣布在11月22 – 24日于新加坡召开的2019年ESMO 亚洲大会上，韩国首尔大学教授兼该研究的研究者Do-Youn...
View ArticleClik here to view.
Zymeworks Highlights Advancing Clinical Collaboration with BeiGene and...
SINGAPORE Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced updated Phase 1 data for single agent ZW25 in heavily...
View ArticleClik here to view.
采用Masimo Patient SafetyNet™和rainbow Acoustic Monitoring®的研究调查术后患者的去氧饱和及呼吸过缓发病率
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，《临床监护和计算杂志》(Journal of Clinical Monitoring and Computing)近期发表了一项研究，日本东京日本医科大学的研究人员采用Masimo Patient SafetyNet™和rainbow Acoustic Monitoring®...
View ArticleClik here to view.
Heartseed Raises $26M in Series B Funding to Accelerate Development of...
TOKYO Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure (HF), today announced it has raised 2.8 Billion-yen...
View ArticleClik here to view.
Phenomics Health Inc. Acquires Patented Pharmacometabolomic Technology
ANN ARBOR, Mich. Phenomics Health Inc., a bioinformatics platform-based precision medicine company, today announced it has acquired the patented pharmacometabolomic technology portfolio of Precera...
View ArticleClik here to view.
Takeda Presents Long-Term Data in ALK+ NSCLC Showing ALUNBRIG® (brigatinib)...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced updated data from the Phase 3 ALTA-1L trial, which evaluated ALUNBRIG versus crizotinib...
View Article